83
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan

, , , , , , & show all
Pages 491-497 | Received 14 Sep 2011, Accepted 09 Nov 2011, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Syuji Takei, Naomi Iwata, Ichiro Kobayashi, Toru Igarashi, Yoko Yoshinaga, Naoko Matsubara, Naomi Sunaga, Ayumi Ito & Shumpei Yokota. (2021) Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study. Modern Rheumatology 31:2, pages 421-430.
Read now
Nami Okamoto, Shumpei Yokota, Syuji Takei, Yuka Okura, Tomohiro Kubota, Masaki Shimizu, Tomo Nozawa, Naomi Iwata, Hiroaki Umebayashi, Noriko Kinjo, Tomoko Kunishima, Junko Yasumura & Masaaki Mori. (2019) Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018. Modern Rheumatology 29:1, pages 41-59.
Read now

Articles from other publishers (2)

Masaaki Mori, Masao Nakagawa, Nao Tsuchida, Kou Kawada, Junko Sato, Michiyo Sakiyama, Shinya Hirano, Katsuaki Sato & Hidefumi Nakamura. (2018) Proposal for the development of biologics in pediatric rheumatology. Pediatrics International 60:2, pages 108-114.
Crossref
G. Lapadula, A. Marchesoni, A. Armuzzi, C. Blandizzi, R. Caporali, S. Chimenti, R. Cimaz, L. Cimino, P. Gionchetti, G. Girolomoni, P. Lionetti, A. Marcellusi, F.S. Mennini & C. Salvarani. (2014) Adalimumab in the Treatment of Immune-Mediated Diseases. International Journal of Immunopathology and Pharmacology 27:1_suppl, pages 33-48.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.